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Acute myocardial infarction continues to be a major cause of mortality and morbidity, and infarct size is the major determinant of patients' prognosis. The only way to reduce infarct size is to restore coronary blood flow; however, reperfusion not only salvages myocardium from infarction, but also brings about additional 'reperfusion injury'. Ischaemic post-conditioning, i.e. the repeated mechanical brief interruption of coronary blood flow during early reperfusion, attenuates reperfusion injury and reduces the ultimate infarct size. 1,2 Ischaemic post-conditioning was first characterized in dogs 3 and confirmed in all species tested so far, provided they were young and healthy. 4 Staat et al. in a landmark proof-of-concept study translated the experimental finding to a small cohort of select patients with acute myocardial infarction; the cumulative creatine kinase (CK) release during reperfusion was reduced by a protocol of four cycles of 1 min angioplasty balloon inflation/1 min deflation before full reperfusion. The cumulative CK release vs. the area at risk, as determined using ventriculography before reperfusion from the abnormally contracting myocardium, was also reduced. 5 Reduction of infarct size by ischaemic post-conditioning in patients with acute myocardial infarction was subsequently confirmed in a number of small studies, using as endpoints CK 6 -9 or troponin release, 9 ECG ST-segment resolution, 8 and anatomic infarct size, as determined by single photon emission computed tomography 7, 9 or delayed enhancement magnetic resonance imaging (MRI) 10 . A more long-term benefit from ischaemic post-conditioning was seen in echocardiographic wall motion after 8 weeks 6 or left ventricular ejection fraction (LVEF) after 1 year. 9 One recent study 11 using the same ischaemic post-conditioning algorithm of four cycles of 1 min re-occlusion/reperfusion found no protection in terms of either CK and troponin release or infarct size by MRI. Now, a study by Freixa et al. 12 also does not confirm protection by ischaemic post-conditioning, again using the established algorithm of four cycles of 1 min re-occlusion/reperfusion: CK release was not reduced, and troponin I release was even enhanced. Infarct size, as determined from delayed enhancement MRI, was not reduced, nor was the relationship of infarct size to area at risk, as determined from coronary angiography using the BARI score. 13 A calculated myocardial salvage ratio was even less with ischaemic post-conditioning. Whereas control patients had a slight improvement of LVEF over 6 months by MRI, patients undergoing an ischaemic post-conditioning protocol did not. These two recent negative studies on ischaemic post-conditioning are disturbing, but also welcome because they challenge and make us critically re-examine the prevailing concept of cardioprotection before its broader translation to clinical practice. Technically, both negative studies used MRI, although both avoided the Achilles heel of MRI-based infarct size assessment, i.e. the quantification of area at risk from T2 weighted oedema, 14 but used either ventriculography 11 or angiography 12 to this end.
Both also found no protection in terms of CK or troponin release, although it is unfortunate that in the study of Freixa et al. the area under the curve for CK was not reported, which would be less dependent than peak CK on release kinetics in the presence of microvascular obstruction. Also, no long-term benefit for LVEF was seen with either echocardiography or MRI in the study of Freixa et al., and therefore the apparent lack of protection in this study 12 and the previous 11 negative study cannot just be ascribed to the use of MRI. One technical issue which remains of concern is the extension of error bars in the myocardial salvage index far into the negative range, reflecting an infarct size larger than the area at risk and emphasizing the limited spatial resolution of this approach; this technical problem was more prominent in the ischaemic post-conditioning group than in the control group. Biologically, ischaemic post-conditioning as first characterized in animal experiments is a healthy heart phenomenon, and its translation to clinical practice cannot be taken for granted. In fact, a number of conditions have been identified which attenuate or abrogate protection by ischaemic post-conditioning ( Figure 1 ).
2,4
Notably, protection by ischaemic post-conditioning is lost with age. 15 Also, a number of co-morbidities which are frequently present in patients suffering from acute myocardial infarction are related to loss of protection by ischaemic post-conditioning, including hypercholesterolaemia, diabetes, obesity, hypertension, and LV hypertrophy, and some medications, such as b-blockade, statins, or antidiabetic drugs, also interfere with cardioprotection 2 . However, it is not only the attenuation of protection in the ischaemic post-conditioning group, but also the potential recruitment of protection in the control group which might minimize any difference between ischaemic post-conditioning and control. In fact, a number of medications can recruit cardioprotection, notably adenosine, 16 nitroglycerin, 17 b-blockers, 18 angiotensinconverting enzyme (ACE) inhibitors, 19 AT 1 -blockers, 20 statins, 21 ivabradine, 22 and dronedarone. 23 Of particular importance for potential differences or the lack thereof between ischaemic postconditioning and control is the status of the coronary circulation. 24 Coronary microembolization prior to complete coronary occlusion with impending infarction can induce cardioprotection. 25 A potential interference of coronary microembolization with protection by ischaemic post-conditioning has not been studied yet, but is conceivable since embolized myocardium in the absence of reperfusion cannot be protected. Conversely, reperfusion through a residual stenosis, i.e. gentle reperfusion, attenuates reperfusion injury and reduces infarct size as evidenced in pigs. 26 In this respect, the use of direct stenting is of major importance: direct stenting reduces coronary microembolization 27 and establishes immediate full reperfusion. Therefore, direct stenting might abrogate potential protection by reperfusion through a residual stenosis in the control group and eliminates potential interference of coronary microembolization with protection in the ischaemic post-conditioning group, thus maximizing a potential difference. Considering the above confounders, the much lower use of direct stenting (only in 50% of patients), the use of adenosine and/or nitroglycerin in many patients, and the slightly higher proportion of diabetics in the present study could easily have cooperated to obscure the protection by ischaemic postconditioning, which was seen in the original study by Ovize's group. While such considerations reconcile the existing positive and negative studies without questioning the validity of either one, it raises the concern about the importance of the ischaemic post-conditioning phenomenon and its translation to clinical use. After all, the confounding co-morbidities, co-medications, and interventional procedures are all part of clinical reality. In my view, the mechanical procedure of ischaemic post-conditioning may indeed not become broadly applicable to recruit protection in clinical routine. However, the recognition of its potential and a better understanding of its underlying signal transduction 28 may provide an important paradigm for cardioprotection and its translation to clinical use of pharmacological interventions. 
